Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Zeripatamig by Light Chain Bioscience for Marginal Zone B-cell Lymphoma: Likelihood of Approval
Zeripatamig is under clinical development by Light Chain Bioscience and currently in Phase I for Marginal Zone B-cell Lymphoma. According...
Zeripatamig by Light Chain Bioscience for Diffuse Large B-Cell Lymphoma: Likelihood of Approval
Zeripatamig is under clinical development by Light Chain Bioscience and currently in Phase I for Diffuse Large B-Cell Lymphoma. According...
Zeripatamig by Light Chain Bioscience for Follicular Lymphoma: Likelihood of Approval
Zeripatamig is under clinical development by Light Chain Bioscience and currently in Phase I for Follicular Lymphoma. According to GlobalData,...